|
[1]
|
Stein, J.D., et al. (2012) The Relationship between Statin Use and Open-Angle Glaucoma. Ophthalmology, 119, 2074-2081.
http://dx.doi.org/10.1016/j.ophtha.2012.04.029
|
|
[2]
|
Leung, D.Y., et al. (2010) Simvastatin and Disease Stabilization in Normal Tension Glaucoma: A Cohort Study. Ophthalmology, 117, 471-476.
http://dx.doi.org/10.1016/j.ophtha.2009.08.016
|
|
[3]
|
Schmeer, C., Kretz, A. and Isenmann, S. (2006) Statin-Mediated Protective Effects in the Central Nervous System: General Mechanisms and Putative Role of Stress Proteins. Restorative Neurology and Neuroscience, 24, 79-95.
|
|
[4]
|
Chen, C.H., et al. (2013) Rosuvastatin Inhibits Pressure-Induced Fibrotic Responses via the Expression Regulation of Prostacyclin and Prostaglandin E2 in Rat Renal Tubular Cells. European Journal of Pharmacology, 700, 65-73.
http://dx.doi.org/10.1016/j.ejphar.2012.12.017
|
|
[5]
|
Schaafsma, D., et al. (2011) Simvastatin Inhibits TGFbeta1-Induced Fibronectin in Human Airway Fibroblasts. Respiratory Research, 12, 113.
http://dx.doi.org/10.1186/1465-9921-12-113
|
|
[6]
|
Watts, K.L., et al. (2005) Simvastatin Inhibits Growth Factor Expression and Modulates Profibrogenic Markers in Lung Fibroblasts. American Journal of Respiratory Cell and Molecular Biology, 32, 290-300.
http://dx.doi.org/10.1165/rcmb.2004-0127OC
|
|
[7]
|
Cordle, A., et al. (2005) Mechanisms of Statin-Mediated Inhibition of Small G-Protein Function. Journal of Biological Chemistry, 280, 34202-34209.
http://dx.doi.org/10.1074/jbc.M505268200
|
|
[8]
|
Laufs, U., et al. (2000) Neuroprotection Mediated by Changes in the Endothelial Actin Cytoskeleton. Journal of Clinical Investigation, 106, 15-24.
http://dx.doi.org/10.1172/JCI9639
|
|
[9]
|
Kato, T., et al. (2004) Statin Blocks Rho/Rho-Kinase Signalling and Disrupts the Actin Cytoskeleton: Relationship to Enhancement of LPS-Mediated Nitric Oxide Synthesis in Vascular Smooth Muscle Cells. Biochimica et Biophysica Acta, 1689, 267-272.
http://dx.doi.org/10.1016/j.bbadis.2004.04.006
|
|
[10]
|
Quigley, H.A., et al. (1981) Optic Nerve Damage in Human Glaucoma. II. The Site of Injury and Susceptibility to Damage. Archives of Ophthalmology, 99, 635-649.
http://dx.doi.org/10.1001/archopht.1981.03930010635009
|
|
[11]
|
Quigley, H.A. and Broman, A.T. (2006) The Number of People with Glaucoma Worldwide in 2010 and 2020. British Journal of Ophthalmology, 90, 262-267.
http://dx.doi.org/10.1136/bjo.2005.081224
|
|
[12]
|
Lambert, W., et al. (2001) Neurotrophin and Neurotrophin Receptor Expression by Cells of the Human Lamina Cribrosa. Investigative Ophthalmology & Visual Science, 42, 2315-2323.
|
|
[13]
|
Cassard, S.D., et al. (2012) Regional Variations and Trends in the Prevalence of Diagnosed Glaucoma in the Medicare Population. Ophthalmology, 119, 1342-1351.
http://dx.doi.org/10.1016/j.ophtha.2012.01.032
|
|
[14]
|
Hernandez, M.R. and Pena, J.D. (1997) The Optic Nerve Head in Glaucomatous Optic Neuropathy. Archives of Ophthalmology, 115, 389-395.
http://dx.doi.org/10.1001/archopht.1997.01100150391013
|
|
[15]
|
Hernandez, M.R., Andrzejewska, W.M. and Neufeld, A.H. (1990) Changes in the Extracellular Matrix of the Human Optic Nerve Head in Primary Open-Angle Glaucoma. American Journal of Ophthalmology, 109, 180-188.
http://dx.doi.org/10.1016/S0002-9394(14)75984-7
|
|
[16]
|
Roberts, M.D., et al. (2010) Changes in the Biomechanical Response of the Optic Nerve Head in Early Experimental Glaucoma. Investigative Ophthalmology & Visual Science, 51, 5675-5684.
http://dx.doi.org/10.1167/iovs.10-5411
|
|
[17]
|
Fautsch, M.P. and Johnson, D.H. (2006) Aqueous Humor Outflow: What Do We Know? Where Will It Lead Us? Investigative Ophthalmology & Visual Science, 47, 4181-4187.
http://dx.doi.org/10.1167/iovs.06-0830
|
|
[18]
|
Johnson, M. (2006) What Controls Aqueous Humour Outflow Resistance? Experimental Eye Research, 82, 545-557.
http://dx.doi.org/10.1016/j.exer.2005.10.011
|
|
[19]
|
Kirwan, R.P., et al. (2009) Differential Global and Extra-Cellular Matrix Focused Gene Expression Patterns between Normal and Glaucomatous Human Lamina Cribrosa Cells. Molecular Vision, 15, 76-88.
|
|
[20]
|
Liu, Y., et al. (2013) Gene Expression Profile in Human Trabecular Meshwork with Primary Open Angle Glaucoma. Investigative Ophthalmology & Visual Science, 54, 6382-6389.
|
|
[21]
|
Coleman, A.L., et al. (1991) Displacement of the Optic Nerve Head by Acute Changes in Intraocular Pressure in Monkey Eyes. Ophthalmology, 98, 35-40.
http://dx.doi.org/10.1016/S0161-6420(91)32345-5
|
|
[22]
|
Hernandez, M.R. (1992) Ultrastructural Immunocytochemical Analysis of Elastin in the Human Lamina Cribrosa. Changes in Elastic Fibers in Primary Open-Angle Glaucoma. Investigative Ophthalmology & Visual Science, 33, 2891-2903.
|
|
[23]
|
Quigley, H.A., et al. (2000) Retrograde Axonal Transport of BDNF in Retinal Ganglion Cells Is Blocked by Acute IOP Elevation in Rats. Investigative Ophthalmology & Visual Science, 41, 3460-3466.
|
|
[24]
|
Hernandez, M.R., Igoe, F. and Neufeld, A.H. (1988) Cell Culture of the Human Lamina Cribrosa. Investigative Ophthalmology & Visual Science, 29, 78-89.
|
|
[25]
|
Kirwan, R.P., et al. (2005) Influence of Cyclical Mechanical Strain on Extracellular Matrix Gene Expression in Human Lamina Cribrosa Cells in Vitro. Molecular Vision, 11, 798-810.
|
|
[26]
|
Kirwan, R.P., et al. (2005) Transforming Growth Factor-Beta-Regulated Gene Transcription and Protein Expression in Human GFAP-Negative Lamina Cribrosa Cells. Glia, 52, 309-324.
http://dx.doi.org/10.1002/glia.20247
|
|
[27]
|
Quill, B., et al. (2011) The Effect of Graded Cyclic Stretching on Extracellular Matrix-Related Gene Expression Profiles in Cultured Primary Human Lamina Cribrosa Cells. Investigative Ophthalmology & Visual Science, 52, 1908-1915.
http://dx.doi.org/10.1167/iovs.10-5467
|
|
[28]
|
Wallace, D.M., et al. (2013) Anti-Connective Tissue Growth Factor Antibody Treatment Reduces Extracellular Matrix Production in Trabecular Meshwork and Lamina Cribrosa Cells. Investigative Ophthalmology & Visual Science, 54, 7836-7848.
http://dx.doi.org/10.1167/iovs.13-12494
|
|
[29]
|
Pattabiraman, P.P., Maddala, R. and Rao, P.V. (2014) Regulation of Plasticity and Fibrogenic Activity of Trabecular Meshwork Cells by Rho GTPase Signaling. Journal of Cellular Physiology, 229, 927-942.
http://dx.doi.org/10.1002/jcp.24524
|
|
[30]
|
Honjo, M., et al. (2001) Effects of Rho-Associated Protein Kinase Inhibitor Y-27632 on Intraocular Pressure and Outflow Facility. Investigative Ophthalmology & Visual Science, 42, 137-144.
|
|
[31]
|
Tanihara, H., et al. (2013) Phase 2 Randomized Clinical Study of a Rho Kinase Inhibitor, K-115, in Primary Open-Angle Glaucoma and Ocular Hypertension. American Journal of Ophthalmology, 156, 731-736.
http://dx.doi.org/10.1016/j.ajo.2013.05.016
|
|
[32]
|
Goldstein, J.L. and Brown, M.S. (1990) Regulation of the Mevalonate Pathway. Nature, 343, 425-430.
http://dx.doi.org/10.1038/343425a0
|
|
[33]
|
Van Aelst, L. and D’Souza-Schorey, C. (1997) Rho GTPases and Signaling Networks. Genes Development, 11, 2295-2322.
http://dx.doi.org/10.1101/gad.11.18.2295
|
|
[34]
|
Burridge, K. and Wennerberg, K. (2004) Rho and Rac Take Center Stage. Cell, 116, 167-179.
http://dx.doi.org/10.1016/S0092-8674(04)00003-0
|
|
[35]
|
Gaw, A. (2000) Statins: The HMG CoA Reductase Inhibitors in Perspective. Martin Dunitz Ltd.
|
|
[36]
|
Cilla Jr., D.D., et al. (1996) Pharmacodynamic Effects and Pharmacokinetics of Atorvastatin after Administration to Normocholesterolemic Subjects in the Morning and Evening. The Journal of Clinical Pharmacology, 36, 604-609.
http://dx.doi.org/10.1002/j.1552-4604.1996.tb04224.x
|
|
[37]
|
Tse, F.L., Jaffe, J.M. and Troendle, A. (1992) Pharmacokinetics of Fluvastatin after Single and Multiple Doses in Normal Volunteers. The Journal of Clinical Pharmacology, 32, 630-638.
http://dx.doi.org/10.1002/j.1552-4604.1992.tb05773.x
|
|
[38]
|
Pan, H.Y., et al. (1990) Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and Lovastatin. The Journal of Clinical Pharmacology, 30, 1128-1135.
http://dx.doi.org/10.1002/j.1552-4604.1990.tb01856.x
|
|
[39]
|
Kajinami, K., Mabuchi, H. and Saito, Y. (2000) NK-104: A Novel Synthetic HMG-CoA Reductase Inhibitor. Expert Opinion on Investigational Drugs, 9, 2653-2661.
http://dx.doi.org/10.1517/13543784.9.11.2653
|
|
[40]
|
Bottorff, M. and Hansten, P. (2000) Long-Term Safety of Hepatic Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitors: The Role of Metabolism-Monograph for Physicians. Archives of Internal Medicine, 160, 2273-2280.
http://dx.doi.org/10.1001/archinte.160.15.2273
|
|
[41]
|
Knopp, R.H. (1999) Drug Treatment of Lipid Disorders. The New England Journal of Medicine, 341, 498-511.
http://dx.doi.org/10.1056/NEJM199908123410707
|
|
[42]
|
McKenney, J.M., et al. (2003) Comparison of the Efficacy of Rosuvastatin versus Atorvastatin, Simvastatin, and Pravastatin in Achieving Lipid Goals: Results from the STELLAR Trial. Current Medical Research and Opinion, 19, 689-698.
http://dx.doi.org/10.1185/030079903125002405
|
|
[43]
|
Olsson, A.G., et al. (2001) Effect of Rosuvastatin on Low-Density Lipoprotein Cholesterol in Patients with Hypercholesterolemia. American Journal of Cardiology, 88, 504-508.
http://dx.doi.org/10.1016/S0002-9149(01)01727-1
|
|
[44]
|
Black, D.M. (2002) A General Assessment of the Safety of HMG CoA Reductase Inhibitors (Statins). Current Atherosclerosis Reports, 4, 34-41.
http://dx.doi.org/10.1007/s11883-002-0060-0
|
|
[45]
|
Ballantyne, C.M., et al. (2003) Risk for Myopathy with Statin Therapy in High-Risk Patients. Archives of Internal Medicine, 163, 553-564.
http://dx.doi.org/10.1001/archinte.163.5.553
|
|
[46]
|
Scandinavian Simvastatin Survival Study Group (1994) Randomised Trial of Cholesterol Lowering in 4444 Patients with Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4S). The Lancet, 344, 1383-1389.
|
|
[47]
|
Shepherd, J., et al. (1995) Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia. West of Scotland Coronary Prevention Study Group. The New England Journal of Medicine, 333, 1301-1307.
http://dx.doi.org/10.1056/NEJM199511163332001
|
|
[48]
|
Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of Cholesterol Lowering with Simvastatin in 20,536 High-Risk Individuals: A Randomised Placebo-Controlled Trial. The Lancet, 360, 7-22.
http://dx.doi.org/10.1016/S0140-6736(02)09327-3
|
|
[49]
|
Horwich, T.B., MacLellan, W.R. and Fonarow, G.C. (2004) Statin Therapy Is Associated with Improved Survival in Ischemic and Non-Ischemic Heart Failure. Journal of the American College of Cardiology, 43, 642-648.
http://dx.doi.org/10.1016/j.jacc.2003.07.049
|
|
[50]
|
Wassmann, S., et al. (2001) Inhibition of Geranylgeranylation Reduces Angiotensin II-Mediated Free Radical Production in Vascular Smooth Muscle Cells: Involvement of Angiotensin AT1 Receptor Expression and Rac1 GTPase. Molecular Pharmacology, 59, 646-654.
|
|
[51]
|
Liu, M., et al. (2009) Atorvastatin Improves Endothelial Function and Cardiac Performance in Patients with Dilated Cardiomyopathy: The Role of Inflammation. Cardiovascular Drugs and Therapy, 23, 369-376.
http://dx.doi.org/10.1007/s10557-009-6186-3
|
|
[52]
|
Landmesser, U., et al. (2005) Simvastatin versus Ezetimibe: Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans. Circulation, 111, 2356-2363.
http://dx.doi.org/10.1161/01.CIR.0000164260.82417.3F
|
|
[53]
|
Gil-Nunez, A.C. and Villanueva, J.A. (2001) Advantages of Lipid-Lowering Therapy in Cerebral Ischemia: Role of HMG-CoA Reductase Inhibitors. Cerebrovascular Diseases, 11, 85-95.
http://dx.doi.org/10.1159/000049130
|
|
[54]
|
Vaughan, C.J., Delanty, N. and Basson, C.T. (2001) Statin Therapy and Stroke Prevention. Current Opinion in Cardiology, 16, 219-224.
http://dx.doi.org/10.1097/00001573-200107000-00001
|
|
[55]
|
Mancini, G.B., et al. (2006) Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients with Chronic Obstructive Pulmonary Disease. Journal of the American College of Cardiology, 47, 2554-2560.
http://dx.doi.org/10.1016/j.jacc.2006.04.039
|
|
[56]
|
Soyseth, V., et al. (2007) Statin Use Is Associated with Reduced Mortality in COPD. European Respiratory Journal, 29, 279-283.
http://dx.doi.org/10.1183/09031936.00106406
|
|
[57]
|
Murphy, D.M., et al. (2008) Simvastatin Attenuates Release of Neutrophilic and Remodeling Factors from Primary Bronchial Epithelial Cells Derived from Stable Lung Transplant Recipients. American Journal of Physiology-Lung Cellular and Molecular Physiology, 294, L592-L599.
http://dx.doi.org/10.1152/ajplung.00386.2007
|
|
[58]
|
Ito, T., et al. (2002) Regulation of Interleukin-8 Expression by HMG-CoA Reductase Inhibitors in Human Vascular Smooth Muscle Cells. Atherosclerosis, 165, 51-55.
http://dx.doi.org/10.1016/S0021-9150(02)00194-6
|
|
[59]
|
Newton, C.J., et al. (2002) Statin-Induced Apoptosis of Vascular Endothelial Cells Is Blocked by Dexamethasone. Journal of Endocrinology, 174, 7-16.
http://dx.doi.org/10.1677/joe.0.1740007
|
|
[60]
|
Shishehbor, M.H., et al. (2003) Statins Promote Potent Systemic Antioxidant Effects through Specific Inflammatory Pathways. Circulation, 108, 426-431.
http://dx.doi.org/10.1161/01.CIR.0000080895.05158.8B
|
|
[61]
|
Geng, Q., et al. (2014) Meta-Analysis of the Effect of Statins on Renal Function. American Journal of Cardiology, 114, 562-570.
http://dx.doi.org/10.1016/j.amjcard.2014.05.033
|
|
[62]
|
Li, Y.B., et al. (2011) Effect of Simvastatin on Expression of Transforming Growth Factor-Beta and Collagen Type IV in Rat Mesangial Cells. Pharmacology, 88, 188-192.
http://dx.doi.org/10.1159/000330739
|
|
[63]
|
Rodrigues Diez, R., et al. (2010) Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-Beta-Independent Process. PLoS ONE, 5, e14145.
http://dx.doi.org/10.1371/journal.pone.0014145
|
|
[64]
|
Solini, A., et al. (2011) Angiotensin-II and Rosuvastatin Influence Matrix Remodeling in Human Mesangial Cells via Metalloproteinase Modulation. Journal of Hypertension, 29, 1930-1939.
http://dx.doi.org/10.1097/HJH.0b013e32834abceb
|
|
[65]
|
Ko, J.H., et al. (2012) HMG-CoA Reductase Inhibitors (Statins) Reduce Hypertrophic Scar Formation in a Rabbit Ear Wounding Model. Plastic and Reconstructive Surgery, 129, 252e-261e.
http://dx.doi.org/10.1097/PRS.0b013e31823aea10
|
|
[66]
|
Dinarvand, P., et al. (2013) Novel Approach to Reduce Postsurgical Adhesions to a Minimum: Administration of Losartan plus Atorvastatin Intraperitoneally. Journal of Surgical Research, 181, 91-98.
http://dx.doi.org/10.1016/j.jss.2012.05.035
|
|
[67]
|
Lalountas, M., et al. (2012) Postoperative Adhesion Prevention Using a Statin-Containing Cellulose Film in an Experimental Model. British Journal of Surgery, 99, 423-429.
http://dx.doi.org/10.1002/bjs.7817
|
|
[68]
|
McGwin Jr., G., et al. (2004) Statins and Other Cholesterol-Lowering Medications and the Presence of Glaucoma. Archives of Ophthalmology, 122, 822-826.
http://dx.doi.org/10.1001/archopht.122.6.822
|
|
[69]
|
De Castro, D.K., et al. (2007) Effect of Statin Drugs and Aspirin on Progression in Open-Angle Glaucoma Suspects Using Confocal Scanning Laser Ophthalmoscopy. Clinical & Experimental Ophthalmology, 35, 506-513.
http://dx.doi.org/10.1111/j.1442-9071.2007.01529.x
|
|
[70]
|
Owen, C.G., et al. (2010) Hypotensive Medication, Statins, and the Risk of Glaucoma. Investigative Ophthalmology & Visual Science, 51, 3524-3530.
http://dx.doi.org/10.1167/iovs.09-4821
|
|
[71]
|
Iskedjian, M., et al. (2009) Effect of Selected Antihypertensives, Antidiabetics, Statins and Diuretics on Adjunctive Medical Treatment of Glaucoma: A Population Based Study. Current Medical Research and Opinion, 25, 1879-1888.
http://dx.doi.org/10.1185/03007990903035083
|
|
[72]
|
Garcia, I.M., et al. (2012) Caveolin-1-eNOS/Hsp70 Interactions Mediate Rosuvastatin Antifibrotic Effects in Neonatal Obstructive Nephropathy. Nitric Oxide, 27, 95-105.
http://dx.doi.org/10.1016/j.niox.2012.05.006
|
|
[73]
|
Tang, X.L., et al. (2011) Atorvastatin Therapy during the Peri-Infarct Period Attenuates Left Ventricular Dysfunction and Remodeling after Myocardial Infarction. PLoS ONE, 6, e25320.
http://dx.doi.org/10.1371/journal.pone.0025320
|
|
[74]
|
Villarreal Jr., G., et al. (2014) Pharmacological Regulation of SPARC by Lovastatin in Human Trabecular Meshwork Cells. Investigative Ophthalmology & Visual Science, 55, 1657-1665.
http://dx.doi.org/10.1167/iovs.13-12712
|
|
[75]
|
Pahan, K., et al. (1997) Lovastatin and Phenylacetate Inhibit the Induction of Nitric Oxide Synthase and Cytokines in Rat Primary Astrocytes, Microglia, and Macrophages. Journal of Clinical Investigation, 100, 2671-2679.
http://dx.doi.org/10.1172/JCI119812
|
|
[76]
|
Krempler, K., et al. (2011) Simvastatin Improves Retinal Ganglion Cell Survival and Spatial Vision after Acute Retinal Ischemia/Reperfusion in Mice. Investigative Ophthalmology & Visual Science, 52, 2606-2618.
http://dx.doi.org/10.1167/iovs.10-6005
|
|
[77]
|
Tanaka, S., et al. (2013) Statins Exert the Pleiotropic Effects through Small GTP-Binding Protein Dissociation Stimulator Upregulation with a Resultant Rac1 Degradation. Arteriosclerosis, Thrombosis, and Vascular Biology, 33, 1591-1600.
http://dx.doi.org/10.1161/ATVBAHA.112.300922
|
|
[78]
|
Rao, P.V., et al. (2001) Modulation of Aqueous Humor Outflow Facility by the Rho Kinase-Specific Inhibitor Y-27632. Investigative Ophthalmology & Visual Science, 42, 1029-1037.
|
|
[79]
|
Allal, C., et al. (2000) RhoA Prenylation Is Required for Promotion of Cell Growth and Transformation and Cytoskeleton Organization but Not for Induction of Serum Response Element Transcription. The Journal of Biological Chemistry, 275, 31001-31008.
http://dx.doi.org/10.1074/jbc.M005264200
|
|
[80]
|
Lebowitz, P.F., Du, W. and Prendergast, G.C. (1997) Prenylation of RhoB Is Required for Its Cell Transforming Function but Not Its Ability to Activate Serum Response Element-Dependent Transcription. The Journal of Biological Chemistry, 272, 16093-16095.
http://dx.doi.org/10.1074/jbc.272.26.16093
|
|
[81]
|
Ramos, R.F., Sumida, G.M. and Stamer, W.D. (2009) Cyclic Mechanical Stress and Trabecular Meshwork Cell Contractility. Investigative Ophthalmology & Visual Science, 50, 3826-3832.
http://dx.doi.org/10.1167/iovs.08-2694
|
|
[82]
|
Honjo, M., et al. (2001) Effects of Protein Kinase Inhibitor, HA1077, on Intraocular Pressure and Outflow Facility in Rabbit Eyes. Archives of Ophthalmology, 119, 1171-8.
http://dx.doi.org/10.1001/archopht.119.8.1171
|
|
[83]
|
Rao, P.V., et al. (2005) Expression of Dominant Negative Rho-Binding Domain of Rho-Kinase in Organ Cultured Human Eye Anterior Segments Increases Aqueous Humor Outflow. Molecular Vision, 11, 288-297.
|
|
[84]
|
Tanihara, H., et al. (2013) Phase 1 Clinical Trials of a Selective Rho Kinase Inhibitor, K-115. JAMA Ophthalmology, 131, 1288-1295.
http://dx.doi.org/10.1001/jamaophthalmol.2013.323
|
|
[85]
|
Takanashi, Y., et al. (2001) Efficacy of Intrathecal Liposomal Fasudil for Experimental Cerebral Vasospasm after Subarachnoid Hemorrhage. Neurosurgery, 48, 894-900.
|
|
[86]
|
Naraoka, M., et al. (2013) Suppression of the Rho/Rho-Kinase Pathway and Prevention of Cerebral Vasospasm by Combination Treatment with Statin and Fasudil after Subarachnoid Hemorrhage in Rabbit. Translational Stroke Research, 4, 368-374.
http://dx.doi.org/10.1007/s12975-012-0247-9
|
|
[87]
|
Thieme, H., et al. (2000) Mediation of Calcium-Independent Contraction in Trabecular Meshwork through Protein Kinase C and Rho-A. Investigative Ophthalmology & Visual Science, 41, 4240-4246.
|
|
[88]
|
Kameda, T., et al. (2012) The Effect of Rho-Associated Protein Kinase Inhibitor on Monkey Schlemm’s Canal Endothelial Cells. Investigative Ophthalmology & Visual Science, 53, 3092-3103.
|
|
[89]
|
Lu, Z., et al. (2008) The Mechanism of Increasing Outflow Facility by Rho-Kinase Inhibition with Y-27632 in Bovine Eyes. Experimental Eye Research, 86, 271-281.
http://dx.doi.org/10.1016/j.exer.2007.10.018
|
|
[90]
|
Nobes, C.D. and Hall, A. (1995) Rho, Rac, and Cdc42 GTPases Regulate the Assembly of Multimolecular Focal Complexes Associated with Actin Stress Fibers, Lamellipodia, and Filopodia. Cell, 81, 53-62.
http://dx.doi.org/10.1016/0092-8674(95)90370-4
|
|
[91]
|
Kato, T., et al. (2014) Rac1-Dependent Lamellipodial Motility in Prostate Cancer PC-3 Cells Revealed by Optogenetic Control of Rac1 Activity. PLoS ONE, 9, e97749.
http://dx.doi.org/10.1371/journal.pone.0097749
|
|
[92]
|
Sundaresan, M., et al. (1996) Regulation of Reactive-Oxygen-Species Generation in Fibroblasts by Rac1. Biochemical Journal, 318, 379-382.
|
|
[93]
|
Farrell, S.M., et al. (2011) bFGF-Mediated Redox Activation of the PI3K/Akt Pathway in Retinal Photoreceptor Cells. European Journal of Neuroscience, 33, 632-641.
http://dx.doi.org/10.1111/j.1460-9568.2010.07559.x
|
|
[94]
|
Groeger, G., Quiney, C. and Cotter, T.G. (2009) Hydrogen Peroxide as a Cell-Survival Signaling Molecule. Antioxidants Redox Signaling, 11, 2655-2671.
http://dx.doi.org/10.1089/ars.2009.2728
|
|
[95]
|
Rhee, S.G. (2006) Cell Signaling. H2O2, a Necessary Evil for Cell Signaling. Science, 312, 1882-1883.
http://dx.doi.org/10.1126/science.1130481
|
|
[96]
|
Takemoto, M., et al. (2001) Statins as Antioxidant Therapy for Preventing Cardiac Myocyte Hypertrophy. Journal of Clinical Investigation, 108, 1429-1437.
http://dx.doi.org/10.1172/JCI13350
|
|
[97]
|
McElnea, E.M., et al. (2011) Oxidative Stress, Mitochondrial Dysfunction and Calcium Overload in Human Lamina Cribrosa Cells from Glaucoma Donors. Molecular Vision, 17, 1182-1191.
|
|
[98]
|
Sundaresan, P., et al. (2014) Whole-Mitochondrial Genome Sequencing in Primary Open-Angle Glaucoma Using Massively Parallel Sequencing Identifies Novel and Known Pathogenic Variants. Genetics in Medicine, Published Online.
http://dx.doi.org/10.1038/gim.2014.121
|
|
[99]
|
Schlotzer-Schrehardt, U. (2010) Oxidative Stress and Pseudoexfoliation Glaucoma. Klinische Monatsblätter für Augenheilkunde, 227, 108-113.
http://dx.doi.org/10.1055/s-0028-1109977
|
|
[100]
|
Sacca, S.C. and Izzotti, A. (2008) Oxidative Stress and Glaucoma: Injury in the Anterior Segment of the Eye. Progress in Brain Research, 173, 385-407.
http://dx.doi.org/10.1016/S0079-6123(08)01127-8
|
|
[101]
|
Gherghel, D., et al. (2005) Systemic Reduction in Glutathione Levels Occurs in Patients with Primary Open-Angle Glaucoma. Investigative Ophthalmology & Visual Science, 46, 877-883.
http://dx.doi.org/10.1167/iovs.04-0777
|
|
[102]
|
Ferreira, S.M., et al. (2004) Oxidative Stress Markers in Aqueous Humor of Glaucoma Patients. American Journal of Ophthalmology, 137, 62-69.
http://dx.doi.org/10.1016/S0002-9394(03)00788-8
|
|
[103]
|
Sacca, S.C., et al. (2007) Glaucomatous Outflow Pathway and Oxidative Stress. Experimental Eye Research, 84, 389-399.
http://dx.doi.org/10.1016/j.exer.2006.10.008
|
|
[104]
|
Maher, P. and Hanneken, A. (2005) The Molecular Basis of Oxidative Stress-Induced Cell Death in an Immortalized Retinal Ganglion Cell Line. Investigative Ophthalmology & Visual Science, 46, 749-757.
http://dx.doi.org/10.1167/iovs.04-0883
|
|
[105]
|
Luksch, A., et al. (2000) Effects of Systemic NO Synthase Inhibition on Choroidal and Optic Nerve Head Blood Flow in Healthy Subjects. Investigative Ophthalmology & Visual Science, 41, 3080-3084.
|
|
[106]
|
Polak, K., et al. (2007) Altered Nitric Oxide System in Patients with Open-Angle Glaucoma. Archives of Ophthalmology, 125, 494-498.
http://dx.doi.org/10.1001/archopht.125.4.494
|
|
[107]
|
Henry, E., et al. (2006) Altered Endothelin-1 Vasoreactivity in Patients with Untreated Normal-Pressure Glaucoma. Investigative Ophthalmology & Visual Science, 47, 2528-2532.
http://dx.doi.org/10.1167/iovs.05-0240
|
|
[108]
|
Henry, E., et al. (1999) Peripheral Endothelial Dysfunction in Normal Pressure Glaucoma. Investigative Ophthalmology & Visual Science, 40, 1710-1714.
|
|
[109]
|
Liao, J.K. (1994) Inhibition of Gi Proteins by Low Density Lipoprotein Attenuates Bradykinin-Stimulated Release of Endothelial-Derived Nitric Oxide. The Journal of Biological Chemistry, 269, 12987-12992.
|
|
[110]
|
Alderson, L.M., et al. (1986) LDL Enhances Monocyte Adhesion to Endothelial Cells in Vitro. The American Journal of Pathology, 123, 334-342.
|
|
[111]
|
Laufs, U. and Liao, J.K. (1998) Post-Transcriptional Regulation of Endothelial Nitric Oxide Synthase mRNA Stability by Rho GTPase. The Journal of Biological Chemistry, 273, 24266-24271.
http://dx.doi.org/10.1074/jbc.273.37.24266
|
|
[112]
|
Plenz, G.A., Hofnagel, O. and Robenek, H. (2004) Differential Modulation of Caveolin-1 Expression in Cells of the Vasculature by Statins. Circulation, 109, e7-e8.
|
|
[113]
|
Thorleifsson, G., et al. (2010) Common Variants near CAV1 and CAV2 Are Associated with Primary Open-Angle Glaucoma. Nature Genetics, 42, 906-909.
http://dx.doi.org/10.1038/ng.661
|
|
[114]
|
Overby, D.R., et al. (2014) Altered Mechanobiology of Schlemm’s Canal Endothelial Cells in Glaucoma. Proceedings of the National Academy of Sciences of the United States of America, 111, 13876-13881.
http://dx.doi.org/10.1073/pnas.1410602111
|
|
[115]
|
Ulivieri, C. and Baldari, C.T. (2014) Statins: From Cholesterol-Lowering Drugs to Novel Immunomodulators for the Treatment of Th17-Mediated Autoimmune Diseases. Pharmacological Research, 88, 41-52.
http://dx.doi.org/10.1016/j.phrs.2014.03.001
|
|
[116]
|
Gallego, B.I., et al. (2012) IOP Induces Upregulation of GFAP and MHC-II and Microglia Reactivity in Mice Retina Contralateral to Experimental Glaucoma. Journal of Neuroinflammation, 9, 92.
http://dx.doi.org/10.1186/1742-2094-9-92
|
|
[117]
|
Ebneter, A., et al. (2010) Microglial Activation in the Visual Pathway in Experimental Glaucoma: Spatiotemporal Characterization and Correlation with Axonal Injury. Investigative Ophthalmology & Visual Science, 51, 6448-6460.
http://dx.doi.org/10.1167/iovs.10-5284
|
|
[118]
|
Johnson, E.C., et al. (2011) Cell Proliferation and Interleukin-6-Type Cytokine Signaling Are Implicated by Gene Expression Responses in Early Optic Nerve Head Injury in Rat Glaucoma. Investigative Ophthalmology & Visual Science, 52, 504-518.
http://dx.doi.org/10.1167/iovs.10-5317
|
|
[119]
|
Haddadin, R.I., et al. (2009) SPARC-Null Mice Exhibit Lower Intraocular Pressures. Investigative Ophthalmology & Visual Science, 50, 3771-3777.
http://dx.doi.org/10.1167/iovs.08-2489
|
|
[120]
|
Swaminathan, S.S., et al. (2013) Secreted Protein Acidic and Rich in Cysteine (SPARC)-Null Mice Exhibit More Uniform Outflow. Investigative Ophthalmology & Visual Science, 54, 2035-2047. http://dx.doi.org/10.1167/iovs.12-10950
|
|
[121]
|
Oh, D.J., et al. (2013) Overexpression of SPARC in Human Trabecular Meshwork Increases Intraocular Pressure and Alters Extracellular Matrix. Investigative Ophthalmology & Visual Science, 54, 3309-3319.
http://dx.doi.org/10.1167/iovs.12-11362
|
|
[122]
|
Bollinger, K.E., et al. (2011) Quantitative Proteomics: TGFbeta(2) Signaling in Trabecular Meshwork Cells. Investigative Ophthalmology & Visual Science, 52, 8287-8294.
http://dx.doi.org/10.1167/iovs.11-8218
|
|
[123]
|
Von Zee, C.L., et al. (2009) Increased RhoA and RhoB Protein Accumulation in Cultured Human Trabecular Meshwork Cells by Lovastatin. Investigative Ophthalmology & Visual Science, 50, 2816-2823.
http://dx.doi.org/10.1167/iovs.08-2466
|
|
[124]
|
Osborne, N.N., et al. (2004) Retinal Ischemia: Mechanisms of Damage and Potential Therapeutic Strategies. Progress in Retinal and Eye Research, 23, 91-147.
http://dx.doi.org/10.1016/j.preteyeres.2003.12.001
|